Anglikon, 27 March 2023: Vitruvia Medical AG has carried out an authorised capital increase as of today. Receivables in the amount of CHF 1’680’817.50 were offset, for which 672’327 registered shares at CHF 1.00 each were issued. The issue price was CHF 2.50 per registered share. The share capital of Vitruvia Medical AG now amounts to CHF 2,511,578.00.
About Vitruvia
Vitruvia Medical AG is a Swiss investment company focusing on the repair, production and trade of medical devices as well as surgical instruments.
Vitruvia thus combines innovative and sustainable solutions for medical-technical progress, customer benefit and economic success.
Contact:
Vitruvia Medical AG
Markus A. Bertschin
Board of Directors
T +41 44 915 33 78
bertschin@vitruvia-med.com